TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Carter In Last Budget Asks Four Percent Increase For NCI, But Then Seeks $13.5 Million Rescission January 23, 1981
TCL Archive Rauscher Mammography Guidelines Would Limit Annual Use To Members Of High Risk Group August 13, 1976
